C diffense
Research type
Research Study
Full title
Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Toxoid Vaccine in Subjects at Risk for C. difficile Infection
IRAS ID
131006
Contact name
Catherine Cosgrove
Contact email
Sponsor organisation
Sanofi Pasteur Inc.
Eudract number
2013-000775-32
ISRCTN Number
n/a
Research summary
This research study is a vaccine study, Clostridium difficile Toxoid Vaccine, designed to evaluate whether or not this vaccine can protect against a symptomatic bacterial infection caused by the organism Clostridium difficile (known as C. difficile).
REC name
London - Surrey Borders Research Ethics Committee
REC reference
13/LO/0826
Date of REC Opinion
20 Aug 2013
REC opinion
Further Information Favourable Opinion